Surveillance, intervention, and referral to services activities for infants with microcephaly or other adverse outcomes linked with the Zika virus

The Centers for Disease Control and Prevention (CDC) announces CDC-RFA-DD17-1702 for the ten (10) eligible/non-responsive jurisdictions of CDC-RFA-DD16-1605 to apply for fiscal year FY2017 funds to establish, enhance, and maintain rapid population-based surveillance of microcephaly and other adverse outcomes (especially central nervous system (CNS) defects) possibly linked to Zika virus infection during pregnancy using an active case-finding methodology; participate in centralized pooled clinical and surveillance data projects; ensure affected infants and families are referred to services; and assess health and developmental outcomes of these children. This aligns with the National Center on Birth Defects and Developmental Disabilities (NCBDDD) performance goal to “enhance birth defects surveillance, research, and prevention.” This announcement is for non-research activities supported by CDC, i.e., conduct rapid active population-based ascertainment of select major birth defects possibly linked to maternal Zika virus and to use the data for public health action through monitoring, prevention, and intervention.